Kate Stalter | Page 8

More From Kate Stalter

Business News

Is Sanofi A Buy, Despite Recent Stumbles?

Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.
Business News

3 Stocks Setting Up For More Growth In 2022

Investors and traders always want an edge as the calendar flips over to a new year, and Innovative Industrial Properties (NYSE: IIPR), Zscaler (NASDAQ: ZS) and Axcelis Technologies (NASDAQ: ACLS)...

More Authors You Might Like